Two Sigma Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Two Sigma Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,300	Closed	-$368K	–	2424
2024 Q3	$368K	Buy	+3,300	New	+$362K	0.01%	1572
2024 Q1	–	Sell	-2,900	Closed	-$357K	–	3284
2023 Q4	$357K	Sell	2,900 -1,200	-29%	-$150K	﹤0.01%	1841
2023 Q3	$531K	Buy	+4,100	New	+$546K	0.01%	1491
2022 Q2	–	Sell	-2,000	Closed	-$311K	–	2552
2022 Q1	$311K	Buy	+2,000	New	+$290K	0.01%	1374

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Two Sigma Securities's JAZZ Position: Q1 2026 in Review

Two Sigma Securities opened a new position in Jazz Pharmaceuticals (JAZZ) in Q1 2026: 1,065 shares worth $201K. The stake represents 0.02% of the portfolio and ranks #1052 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in JAZZ as recently as Q2 2024.

Two Sigma Securities first reported a position in JAZZ in Q4 2016 and has held it in 12 quarters since. The position peaked at $411K in Q2 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Two Sigma Securities held 1,065 shares of Jazz Pharmaceuticals worth $201K as of Q1 2026.
Jazz Pharmaceuticals was a new Two Sigma Securities position in Q1 2026.
Jazz Pharmaceuticals made up 0.02% of Two Sigma Securities's portfolio in Q1 2026, its #1052 holding.
Two Sigma Securities first reported a position in Jazz Pharmaceuticals in Q4 2016 and has held it in 12 quarters since.
Two Sigma Securities's Jazz Pharmaceuticals position peaked at $411K in Q2 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.